Rituxan

March 26, 2021March 26, 2021

Rituximab Fails to Lessen Brain Inflammation in Progressive MS Trial

News, Rituxan, SPMS

Injecting rituximab — a cancer therapy sometimes used in multiple sclerosis — into the spinal canal of people with progressive forms of MS did not demonstrably lower inflammation or improve clinical ... Read more

May 5, 2017May 21, 2018

Switching from Rituxan to Ocrevus: An Interview with Dr. Timothy Vollmer on Both MS Treatments

News, Ocrevus, Rituxan

A multiple sclerosis (MS) trial now underway in Colorado is assessing the safety and tolerability of switching from Rituxan (rituximab) to Ocrevus (ocrelizumab), and its lead investigator, Dr. Timothy L. Vollmer, largely expects no problems. ... Read more

April 19, 2017July 28, 2020

Are Ocrevus and Rituxan Similar? Neurologists Respond to Patients’ Concerns

News, Ocrevus, Rituxan

While many multiple sclerosis patients celebrated the recent approval of Ocrevus (ocrelizumab), others argued that the drug is largely a rebranded version of rituximab. Rituximab — sold as Rituxan for indications like non-Hodgkin’s ... Read more

Join our email list!